| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase I/II study of fixed-dose-rate gemcitabine and S-1 with concurrent radiotherapy for locally advanced pancreatic cancer
|
Goji, Takahiro
|
|
2015
|
76 |
3 |
p. 615-620
|
article
|
| 2 |
A phase II study of icotinib and whole-brain radiotherapy in Chinese patients with brain metastases from non-small cell lung cancer
|
Fan, Yun
|
|
2015
|
76 |
3 |
p. 517-523
|
article
|
| 3 |
A phase II study of S-1, oxaliplatin, oral leucovorin, and bevacizumab combination therapy (SOLA) in patients with unresectable metastatic colorectal cancer
|
Nishina, Tomohiro
|
|
2015
|
76 |
3 |
p. 547-553
|
article
|
| 4 |
A Phase I study of MEDI-575, a PDGFRα monoclonal antibody, in Japanese patients with advanced solid tumors
|
Murakami, Haruyasu
|
|
2015
|
76 |
3 |
p. 631-639
|
article
|
| 5 |
A phase 1 study of intermittently administered pazopanib in combination with continuous daily dosing of lapatinib in patients with solid tumors
|
Henary, H.
|
|
2015
|
76 |
3 |
p. 597-603
|
article
|
| 6 |
AT-101 inhibits hedgehog pathway activity and cancer growth
|
Wang, Juan
|
|
2015
|
76 |
3 |
p. 461-469
|
article
|
| 7 |
Characterization of the metabolism of benzaldehyde dimethane sulfonate (NSC 281612, DMS612)
|
Parise, Robert A.
|
|
2015
|
76 |
3 |
p. 537-546
|
article
|
| 8 |
Cisplatin-based chronotherapy for advanced non-small cell lung cancer patients: a randomized controlled study and its pharmacokinetics analysis
|
Li, Jie
|
|
2015
|
76 |
3 |
p. 651-655
|
article
|
| 9 |
Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumors
|
Patnaik, Amita
|
|
2015
|
76 |
3 |
p. 587-595
|
article
|
| 10 |
Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma
|
Fogelman, David
|
|
2015
|
76 |
3 |
p. 489-498
|
article
|
| 11 |
Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells
|
Yang, Dan
|
|
2015
|
76 |
3 |
p. 575-586
|
article
|
| 12 |
Inhibition of ovarian cancer cell growth by a novel TAK1 inhibitor LYTAK1
|
Ying, Liu
|
|
2015
|
76 |
3 |
p. 641-650
|
article
|
| 13 |
Integrated nonclinical and clinical risk assessment of the investigational proteasome inhibitor ixazomib on the QTc interval in cancer patients
|
Gupta, Neeraj
|
|
2015
|
76 |
3 |
p. 507-516
|
article
|
| 14 |
In vivo pharmacokinetic and tissue distribution investigation of sustained-release cisplatin implants in the normal esophageal submucosa of 12 beagle dogs
|
Yin, Jia-Xue
|
|
2015
|
76 |
3 |
p. 525-536
|
article
|
| 15 |
Lower antioxidative capacity of multidrug-resistant cancer cells confers collateral sensitivity to protoflavone derivatives
|
Stanković, Tijana
|
|
2015
|
76 |
3 |
p. 555-565
|
article
|
| 16 |
Modeling and simulations relating overall survival to tumor growth inhibition in renal cell carcinoma patients
|
Claret, Laurent
|
|
2015
|
76 |
3 |
p. 567-573
|
article
|
| 17 |
NECTIN-4 increased the 5-FU resistance in colon cancer cells by inducing the PI3K–AKT cascade
|
Das, Dipon
|
|
2015
|
76 |
3 |
p. 471-479
|
article
|
| 18 |
Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer
|
Suleiman, Yaman
|
|
2015
|
76 |
3 |
p. 481-487
|
article
|
| 19 |
Predictive value of STMN1 gene promoter polymorphism (−2166T>C) in patients with advanced NSCLC treated with the combination of platinum compounds and vinorelbine
|
Mlak, Radosław
|
|
2015
|
76 |
3 |
p. 621-629
|
article
|
| 20 |
Reproductive hormone levels and differential mitochondria-related oxidative gene expression as potential mechanisms for gender differences in cardiosensitivity to Doxorubicin in tumor-bearing spontaneously hypertensive rats
|
Gonzalez, Yanira
|
|
2015
|
76 |
3 |
p. 447-459
|
article
|
| 21 |
RETRACTED ARTICLE: ABCB1 (1199G>A) polymorphism regulates the efficacy of docetaxel and imatinib mesylate in HEK293 recombinant cell lines
|
Peng, Rui
|
|
2015
|
76 |
3 |
p. 657
|
article
|
| 22 |
Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate
|
Petrioli, Roberto
|
|
2015
|
76 |
3 |
p. 439-445
|
article
|
| 23 |
Safety of topotecan monotherapy for relapsed small cell lung cancer patients with pre-existing interstitial lung disease
|
Enomoto, Yasunori
|
|
2015
|
76 |
3 |
p. 499-505
|
article
|
| 24 |
S-1 and irinotecan with or without bevacizumab versus 5-fluorouracil and leucovorin plus oxaliplatin with or without bevacizumab in metastatic colorectal cancer: a pooled analysis of four phase II studies
|
Iwasa, Satoru
|
|
2015
|
76 |
3 |
p. 605-614
|
article
|
Journal description